Foresite Capital Management III, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$18,695,000
+37.1%
108,6300.0%25.92%
+79.4%
Q2 2021$13,632,000
-7.5%
108,6300.0%14.45%
+11.7%
Q1 2021$14,731,000
+6.0%
108,6300.0%12.94%
-19.9%
Q4 2020$13,898,000
+13.7%
108,6300.0%16.15%
+77.5%
Q3 2020$12,224,000
+205.3%
108,630
+158.5%
9.10%
+155.7%
Q2 2020$4,004,000
+6.0%
42,0300.0%3.56%
-40.8%
Q1 2020$3,777,000
-72.1%
42,030
-83.5%
6.01%
-20.6%
Q4 2019$13,516,000
+34.2%
254,9230.0%7.58%
+97.0%
Q3 2019$10,072,000
-3.8%
254,9230.0%3.85%
+12.0%
Q2 2019$10,472,000
-11.8%
254,9230.0%3.43%
+11.1%
Q1 2019$11,872,000
+15.6%
254,923
+8.1%
3.09%
-8.4%
Q4 2018$10,272,000
-28.5%
235,868
-6.0%
3.37%
+6.5%
Q3 2018$14,357,000
+6.2%
250,863
-10.0%
3.17%
+8.8%
Q2 2018$13,525,000
+24.1%
278,7530.0%2.91%
+22.7%
Q1 2018$10,899,000
-7.9%
278,7530.0%2.38%
-28.5%
Q4 2017$11,830,000
+13.7%
278,7530.0%3.32%
+15.9%
Q3 2017$10,403,000
+1622.4%
278,753
+1301.8%
2.86%
+1354.3%
Q2 2017$604,000
+14.8%
19,8860.0%0.20%
-2.5%
Q1 2017$526,000
+3.7%
19,8860.0%0.20%
-8.2%
Q4 2016$507,000
-79.6%
19,886
-78.9%
0.22%
-88.6%
Q1 2016$2,491,000
-66.0%
94,403
-37.1%
1.93%
-70.3%
Q4 2015$7,316,000150,0476.49%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders